Articles

How to implement PSMA radioligand therapy in Belgium

BJMO - 2024, issue Special, march 2024

J. Collins PhD, T. Feys MBA, MSc

During the 11th Belgian Multidisciplinary Meeting on Urological Cancers (BMUC) 2024, Prof. Dr. Karolien Goffin (University Hospitals Leuven), Dr. Carlos Artigas (Institut Jules Bordet, Brussels) and Prof. Dr. Nadia Withofs (CHU de Liège) discussed the current challenges in implementing prostate-specific membrane antigen (PSMA) radioligand therapy in Belgium.

Read more

Disparities in oncological care

BJMO - 2024, issue Special, february 2024

J. Collins PhD

At the BMSO Annual Meeting 2024, Dr. Peter Vuylsteke (Medical Oncologist and Head of Department Internal Medicine at the University of Botswana) discussed the treatment disparities in oncological care and provided some suggestions on how to bridge this gap.1 Dr. Vuylsteke began by highlighting that not only is there a disparity in care between low- and middle-income countries (LMIC) and high-income countries (HIC), but disparities also arise due to the outbreak of war and epidemics such as COVID-19. Finally, regional differences in the quality of care exist.

Read more